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Abstract.  Members of the cytokine receptor family 
are composed of several noncovalently linked chains 
with sequence and structure homologies in their ex- 
tracellular domain.  Receptor subfamily members share 
at least one component:  thus the receptors for inter- 
leukin (IL) 2 and ILl5 have common ~ and 3" chains, 
while those for IL2, 4,  7, and 9 have a common 3' 
chain.  The intracellular pathway followed by IL2 
receptors after ligand binding and endocytosis was 
analyzed by immunofluorescence and confocal micros- 
copy in a human T  lymphocytic cell line.  Surprisingly, 
the a, ~, and 3' chains had different intracellular 
localizations after being endocytosed together.  The ct 
chain was always in transferl-in-positive compartments 
(early/recycling endosomes), both at early and late in- 
ternalization  times, but was never detected in 
rab7-positive compartments  (late endosomes). On the 
other hand,  at late internalization  times, the/3 and 3, 
chains were excluded from transferrin-positive  or- 
ganelles and did not colocalize with ~. Furthermore, 
/3 could be found in rab7-positive vesicles. These 
differences suggest that the ot chain recycles to the 
plasma membrane,  while the ~  and 3' chains are 
sorted towards the degradation pathway.  The half-lives 
of these three chains on the cell surface also reflect 
their different intracellular  fates after endocytosis. The 
and 3' chains are very short-lived polypeptides since 
their half-life on the surface is only =1  h,  whereas c~ 
is a much more stable surface protein.  This shows for 
the first time that components of a multimeric receptor 
can be sorted separately along the endocytic pathway. 
T 
rtE cytokine interleukin  2 (IL2) ~ is produced by acti- 
vated helper T lymphocytes and stimulates  prolifera- 
tion and effector functions of a variety of cells of the 
immune system (36, 46, 57). High-affinity IL2 receptors (Kd 
=  10-100 pM) consist of three distinct  components,  the a 
chain (IL2Rc~, 50-55 kD), the/3 chain  (IL2RB, 70-75 kD) 
and the 3' chain (IL2R,y, 65 kD), that are associated in a non- 
covalent manner (36, 57). Both the/3 and ~ chains,  but not 
the c~ chain,  belong to the cytokine receptor superfamily  (1, 
5).  This  hematopoietic cytokine receptor family  includes 
receptors such as IL3R, IL4R, IL5R, IL6R, IL7R,  IL9R, 
IL15R, the erythropoietin receptor,  the granulocyte colony- 
stimulating  factor  receptor,  the  granulocyte-macrophage 
colony-stimulating  factor receptor,  and the leukemia inhibi- 
tory factor receptor.  This family also includes receptor pro- 
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teins for factors that are believed to function normally out- 
side the  immune  and  hematopoietic  system,  i.e.,  growth 
hormone,  prolactin  and  ciliary  neurotrophic  factor.  They 
have an extracellular  =200-amino acid region of structural 
homology that is characterized  by four conserved cysteine 
residues in the amino terminal  half of this region and a Trp- 
Ser-X-Trp-Ser  motif (where  X  is a  non-conserved  amino 
acid) at its carboxy-terminal  end. Recently the IL2R~ chain 
was found to also participate  in the formation of high-affinity 
forms of IL4, IL7, IL9, and ILl5 receptors (19, 32, 33, 39, 
43, 44). IL2P-,~ is also a component of the ILl5 receptor (19). 
IL2R3, plays a critical role in thymic maturation of precursor 
human T lymphocytes since patients suffering from X-linked 
severe combined immunodeficiency  have a mutation in the 
gene encoding  this IL2R3, chain  (9,  10, 40). 
IL2Rc~ is not expressed on resting cells but is strongly and 
transiently  induced following T cell activation (36, 48). The 
expression of high-affinity receptors (IL2Rct/3"y) is transient 
and is preceded by IL2Rot expression.  In addition  to high- 
affinity  receptors,  activated  T  lymphocytes express  low- 
affinity receptors (IL2Rot, K~ =  10 nM) and natural  killer 
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1 nM) (46, 56). The high and intermediate-affinity  receptors 
are capable oflL2 signaling. None of  the IL2 receptor chains 
has tyrosine kinase activity, but protein tyrosine kinases such 
as p5e  ok,  p59  fyn, p53/56 ~',  and JAKs  are  associated with 
IL2 receptors and some have already been shown to be im- 
plicated in signal transduction (2, 6, 28, 29, 31, 37, 43, 50, 
51, 58). IL2 receptor stimulation is coupled to ras signaling 
via Shc and Grb2 (41, 45, 60). 
One of the early events that follows IL2 binding to inter- 
mediate and high-affinity receptors on the cell surface is the 
internalization of IL2 receptor complexes (12, 46, 47). As a 
consequence, high-affinity receptors have a very short half- 
life on the cell surface, about 30 min in the presence of IL2 
(11). This short half-life could have been accounted for by the 
internalization of only one component of the IL2 receptor. 
This does not appear to be the case, however, since the ct and 
/~ chains of high-affinity receptors are internalized together 
with IL2. Furthermore, after 10 min endocytosis, the mul- 
timolecular complex formed between IL2 and the receptor 
chains is found in endocytic compartments (13, 16,  18). 
We have analyzed the intracellular fate of IL2R chains af- 
ter their internalization. The endocytic compartments were 
identified using known markers such as transferrin and rab 
7. The intracellular endocytic pathway of transferrin and its 
receptors  has  been  extensively studied in  numerous  cell 
types. Transferrin accompanies its receptor through the re- 
cycling pathway (7, 30) and thus defines early and recycling 
endocytic organelles. Rab 7, a member of the rab family of 
small GTP-binding proteins, has been localized to late en- 
docytic organelles and is a  marker of such late compart- 
ments (3). 
We have made use of a human tumor cell line, IARC 301.5, 
which constitutively expresses about 3,000 high-affinity IL2 
receptors, internalizes IL2, and proliferates in response to 
this growth factor. Similarly to normal activated T lympho- 
cytes, they also express low-affinity receptors (IL2Ro0 to 
5-  to  10-fold  higher  levels  than high-affinity (IL2Rc~/~3") 
receptors (8, 11). Here we show that in the absence of  protein 
synthesis, IL2P~ and 3, are found in organdies distinct from 
those containing IL2Rot. IL2Rot is colocalized with transfer- 
rin after internalization as part of the IL2-receptor quater- 
nary complex, and both IL2Rt~ and transferrin can be found 
in a  pericentriolar recycling compartment (34,  59).  Also, 
IL2Ro~ is never found in rab 7-positive compartments. On 
the other hand, IL2R~ can be found in late endocytic com- 
partments containing rab 7, and IL2R~ and 3" colocalize only 
partly with transferrin. Therefore, it appears that IL2Rt~ is 
only  found  in  early  and  recycling  compartments  while 
IL2RB and 3' are also detected in late endosomes. In agree- 
ment with these differences in morphology, we have shown 
that IL2P-45, 3', and ct have different half-lives on the cell sur- 
face: IL2P-~ and 3' have a short half-life, about 1 h, whereas 
IL2Ro~ is very stable, with a half-life  of  about 48 h (24). Thus 
the components of  this multimolecular receptor have a differ- 
ent intracellular fate after internalization: one of the chains, 
IL2Rot, recycles to the plasma membrane, while the others, 
IL2RB and %  are destined for degradation. 
Materials and Methods 
Cells, Monoclonal Antibodies, and Reagents 
IARC 301.5 is a subclone from a cell line derived from a human T  lym- 
phoma, that expresses high- and low-affinity  IL2 receptors (II,  14). Cells 
were grown in RPMI 1640,  10% fetal calf serum, I0 mM Hepes, pH 7.2, 
supplemented with glutamine. 
Monoclonal antibodies 7G'/Bt, directed against the ~ chain of IL2 recep- 
tors (42) were obtained from the American Type Culture Collection (Rock- 
ville, MD). The anti-IL2 receptor ~ chain monoclonai antibodies 341 and 
561 were kind gifts from Dr. R. Robb (Dupont Merck Pharmaceutical Co., 
Wilmington, DE) (54),  and the rat monoclonal antibody against human 
IL2R3,,  TUGh4,  was  kindly  provided by  Dr.  K.  Sugamura  (27).  The 
anti-rab 7 purified rabbit antiserum (3) was kindly provided by Dr.  M. 
Zerial (EMBL, Heidelberg, Germany). 
To prepare TRITC-transferrin, human transferrin (Sigma Chem. Co., St. 
Louis,  MO)  was iron loaded (4) and labeled with lissamine rhodamine 
(Eastman Kodak), as described (59). 
lmmunofluorescence and Confocal Microscopy 
Exponentially growing cells, incubated with 50 #M cycloheximide (Sigma 
Chem.  Co.)  and/or 200 pM  IL2  (Roussel Uclaf, Romainville,  France) 
and/or TRITC-transferrin and/or antibodies, were washed twice in cold 
PBS. For all labelings, cells were fixed in 3.7 % paraformaldehyde and 0.03 M 
sucrose for 15 min at 4°C. Subsequent steps were performed at room tem- 
perature. After quenching for 10 min in 50 mM NI-UCI in PBS, the cells 
were washed once in PBS supplemented with 1 mg/ml bovine serum albu- 
min, and permeabilized for 15 min at 37°C in 0.05%  saponin in the buffer 
used for washing. Cells were then incubated, when indicated, with the first 
antibody(ies) in the permcabiliziog buffer for 1 h. After two washes in this 
permeabilizing buffer, the presence  of  antibodies was revealed by incubating 
the cells for I h in permeabilizing buffer containing labeled second antibod- 
ies. After three washes in permeabilizing buffer, and one wash in PBS, the 
cells were mounted in 25 mg/ml 1,4 diacylbicyclo (2.2.2) octane (Dabco; 
Sigma Chem. Co.),  100 mg/mi moviol (Calbiochem-Behring Corp., San 
Diego, CA) 25%  (vol/vol) glycerol, 100 mM Tris-HCi, pH 8.5. 
For 7GTB6, an IgG2a, the second antibodies were either FITC-iabeled 
anti-routine Ig (1/50; Amersham Corp., Arlington Heights, IL) or Texas 
red-labeled anti-IgG2a  (1/25o, Southern Biotechnoiogy, Birmingham, AL). 
For 341, an IgG), the second antibodies were either the same FITC-iabeled 
antibodies, as above, or FITC-labeled anti-IgGt (I/t00; Southern Biotech- 
noiogy) in double labeling experiments with 7G7Bt. For TUGh4 monoclo- 
hal  antibody,  the  second antibody was  FITC-labeled anti-rat  antibody 
(l/10o; Southern Biotechnology). For anti-rab7 rabbit antiserum, the sec- 
ond antibody was TRITC-labeled anti-rabbit Ig (l/t00; Amersham Corp.). 
The samples were examined under a confocal microscope attached to a 
diaplan microscope equipped with a double laser, Argon-Krypton (Leica). 
Bleed-through from the FITC channel to the TRITC/Texas red channel was 
negligible in all experiments. Optical sections were recorded with a 63 x 
lens and a  pinhole aperture such that the thickness of the sections was 
about 0.5/tm. Photographs were taken on Ilford FP4 and Kodak ektachrome 
100 ASA. 
No immunofluorescence staining was ever observed when second anti- 
bodies were used without the first antibody or with an irrelevant first an- 
tibody. 
Endocytosis of Radiolabeled IL2 
Pure recombinant IL2 was radiolabeled with t25iodine by the chloramine 
T method to specific activities of 360 ttCi/#g. For labeling, three successive 
additions of chloramine T were performed within 5 rain at room temperature 
to a final concentration of  25 ~tg/ml. The reaction was stopped after another 
5 rain, and labeled ligand was separated from free t25I by passage through 
an Excellulose GF-5 column (Pierce Chemical Co., Piscataway,  NJ). 
For endocytosis experiments, 2-3  x  106 cells were incubated in 100/~l 
RPMI-Hepes, pH 7.2, 10% FCS, with 200 pM t25I-IL2 at 37°C for various 
times. At the end of the incubation, the cells were washed twice at 4°C to 
remove unbound ligand. They were then subjected to two successive acid 
pH treatments (pH 2.8) to separate cell surface associated from intraceilular 
t25I-IL2 (12). This treatment removed more than 98% of surface associated 
t25I-IL2. Nonspecific binding, measured by adding a 100-fold excess of the 
same unlabeled iigand, was <5% in every case. The data presented here 
show specific binding and internalization. 
The amounts of degraded and undegraded material in medium were de- 
termined by precipitation of undegraded material with 10%  TCA (12). 
Half-Life Measurements 
Cell surface expression of IL2P~ or 3' on cells treated for different times 
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of 200 pM IL2 was assessed by cytot]uorimetry.  The indicated times are 
after a  1 h preineubation in cyeioheximide. 
Surface expression of B and T chains was measured as previously  de- 
scribed by indirect immunotluorescence (24, 25) using the murine mono- 
clonal antibody 341  directed against IL21~ followed by phycoerythrine 
anti-Ig Fab2 (lmmunotech, Luminy,  France) or the rat monoclonal anti- 
body TUC_dt4  directed against IL2R3, followed by FITC-labeled  anti-rat an- 
tibody (Southern Bioteclmology).  Cells were analyzed by flow eytolluorim- 
etry  on  a  FACScan  (Beetou  Dickinson &  Co.,  Mountain View, CA) 
immediately after labeling, and the mean fluorescence  intensity was calcu- 
lated from the recorded data. 
Results 
The a Clua'n of  lL2 Receptors Is Not in the Same 
Endocytic Compartments in T Lymphocytes as the B 
and.r Chains 
Previous experiments demonstrated that both the ot and/~ 
chains of high-affinity IL2 receptors  are internali7e~l  to- 
gether with the ligand 03, 16). To observe the compartments 
reached by IL2 receptors by endocytosis, and not IL2 recep- 
tors along the biosynthetic pathway, the T lymphocytic hu- 
man cell line [ARC 301.5 was incubated with IL2 for 1 h with 
the protein synthesis inhibitor eycloheximide. We have pre- 
viously shown that this cycloheximide incubation is suffi- 
cient to chase out the newly synthesized IL2 receptor chains 
en route to the cell surface (12, 25). The concentration oflL2 
used is sufficient to saturate high-affinity  receptors only, and 
cycloheximide  does not inhibit their internalization although 
it slows it down by a factor two (12,  16, 25). After the one 
hour incubation with cycloheximide and IL2, the cells were 
fixed and permeabilized, and the ot and/~ chains were stained 
with monoclonal antibodies (IgG2a and IgG1) followed by 
subclass specific anti-Ig labeled with Texas red and FITC, 
respectively.  It was checked that these second antibodies 
were indeed subclass specific and did not recognize the ir- 
relevant first antibody. The samples were analyzed by con- 
focal microscopy. Fig. 1 shows a representative medial op- 
tical section of IL2Ra staining (a) and IL2P-~ staining (b). 
When the same experiment was performed in the absence 
of cycloheximide, the same images were obtained showing 
that staining of the biosynthetic pathway is very weak (not 
shown). 
This double staining experiment showed that IL2Rc~ and 
were not colocalized. The intracellular staining was differ- 
ent for IL2Ra and fl: IL2Ro~ appeared as a densely stained 
compartment, while IL21~ staining was weak in this com- 
partment and appeared mostly in vesicles surrounding the 
compartment defined by IL2Rot. 
It is worth noting that IL2Rfl was detected only in intracel- 
lular compartments, while IL2Rc~ was found both inside the 
cells  and  at  the plasma  membrane.  Detection of surface 
IL2Rot is not surprising since these cells express 5-1G-fold 
more IL2Rot than IL21~. These IL2Rot by themselves con- 
stitute the so called low-affinity receptors which are not in- 
ternalized (13, 16,  17,  22,  38).  Also, IL2Rot could not be 
found in intracellnlar vesicles in the absence of IL2, in cells 
in which protein synthesis had been blocked by cyclohexi- 
mide (not shown). IL2R~ is thus internalized only when it 
is part of high-affinity receptors (IL2Rc~, 8, and 3') and not 
when it forms low-affinity  receptors by itself, whether or not 
IL2 is present.  In conclusion, IL2Ra observed intracellu- 
larly was internalized as a component of  the quaternary corn- 
Figure L Localization of IL2R,~, IL2RB, and IL2RT in endocytic 
vesicles after IL2 endocytosis. The cells were incubated for 1 h at 
37°C in the presence of 50 #M cycloheximide  and 200 pM IL2, 
and then fixed and permeabilized. IL2Rc~  and/~ or -y localizations 
were then revealed by incubating the cells with anti-IL2R~ anti- 
body, 7G7B6 (IgG2,),  together with  anti-IL2174~ antibody, 341 
(IgG0 or with anti-IL2RT antibody, TUGh4 (from rat) followed 
by Texas red anti-murine IgG2a and FITC anti-murine IgG~ or 
FITC anti-rat immunoglobulins.  Representative  medial optical cuts 
show (a) IL2Ra and (b) IL2R/~,  or (c) IL2Ra and (d) IL2R3,. Bar, 
10 #m. 
plex  comprised  of the  high-affinity receptors  harboring 
bound IL2. 
Until now nothing was known concerning the internaliza- 
tion of IL2R% since antibodies have become available only 
recently (27). We used the same approach to localize IL2R3, 
in endocytic comparmaents as described above for IL2RB 
and or. Cells in which protein synthesis had been inhibited 
by cycloheximide were allowed to internalize IL2. The cells 
were then fixed and permeabilized, and stained for IL2Ra 
and 3' and analyzed by confocal microscopy. Representative 
medial optical sections of IL2Roe staining (c)  and IL2R3" 
staining (d) are presented in Fig. 1. IL2R3" can be observed 
in intracellular vesicles, and therefore is endocytosed. It is 
not found in the same compartments as IL2Rot and its intra- 
cellular distribution resembles that of IL2P-~. 
The t~ Chain of  lL2R Is Restricted to Early, Sorting 
and Recycling Endosomes 
During receptor-mediated endocytosis, receptors and ligands 
are internalized in transport vesicles that deliver their cargo 
to the endosomal compartment. Some proteins then recycle 
back to the cell surface while others are sorted to a variety 
of destinations. The characterization and nomenclature of 
the endosomal compartments relies on either morphologi- 
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types. They are at the moment difficult to reconcile (53). 
Transferrin remains bound to its receptor throughout its in- 
tracellular journey and recycles with a very high efficiency 
to the plasma membrane.  We used TRITC-transferrin to 
stain the organdies through which it transits, i.e., the early, 
sorting,  and recycling endosomes.  Ligands  and receptors 
destined  to  degradation  are  sorted  from  the  transferrin- 
containing compartments towards late endosomes/prelyso- 
somes and lysosomes. These late endosomes/prelysosomes 
are reached by fluid phase tracers after about 30 min, and 
the small GTP binding protein rab 7 is a specific marker for 
these compartments (3). To define the organelles containing 
the ct chain of IL2 receptors and to get some insight in its 
intracellular fate, we have compared its intracellular location 
with that of these two markers, transferrin and rab 7.  En- 
docytosis of IL2Rot was probed by internalizing IL2 together 
with  a  monoclonal antibody to IL2Rc~,  7G'/B6.  We first 
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Figure 2. Endocytosis and degradation of 12sI-IL2 in the presence 
of anti-IL2R~x,/3, and 7 monocl0nal antibodies. The cells were in- 
cubated at 37*C with 200 pM t2sI-IL2 in the absence of antibody 
(o)  or  in the  presence  of anti-IL2Rc~ antibody 7GTB6 (zx) or 
anti-IL2R/3 antibody 341  (v)  or anti-IL2R3, antibody TUG4h 
(ll). (a) Endocytosis of t2sI-IL2: after the indicated times at 37°C, 
intracellular u~I-IL2 was measured as the radioactivity remaining 
cell associated after acid pH wash, as described in Materials and 
Methods. The ratio of intraceUular to total cell associated radioac- 
tivity is presented. (b) Degradation: the amounts of  degraded radio- 
active material in the medium was measured as non qEA precipita- 
ble. The ratio of degraded to total radioactivity in the extracellular 
medium is presented. 
showed that this antibody does not modify IL2 binding (42) 
and does not affect either IL2 internalization or its degrada- 
tion. For this purpose uq-IL2 was incubated for different 
times  at 37°C  with or without the  anti-IL2Rct antibody, 
under the conditions to be used for confocal microscopy ex- 
periments.  As  shown  in  Fig.  2,  the  presence  of  anti- 
IL2Rt~ antibody does not modify the kinetics of IL2 encyto- 
sis and degradation. To visualize internalized transferrin and 
IL2Ro~,  the  cells  were  incubated  at  37°C  with  150  nM 
TRITC-transferrin, together with IL2 and 7G7B6 antibody. 
The cells were then washed at 4°C, fixed, pcrmeabilized, and 
incubated with a second FITC-labeled anti-murine Ig anti- 
body. The samples were analyzed by confocal microscopy. 
Representative medial optical sections, after 15 and 100 min 
incubation with the ligands at 37°C, are shown in Fig. 3. In- 
tracellular vesicles stained with anti-IL2Rt~ antibody were 
always co-stained with TRITC-transferrin, after 15 min as 
well as after a long time of internalization, 100 rain. After 
15 min endocytosis, transferrin and IL2Rct staining appears 
as small vesicles throughout the cytoplasm. After longer in- 
cubations, e.g.,  100 min, the appearance of the transferrin 
and  IL2Roe  containing  compartment had  changed  and  it 
appeared as a juxta-nuclear compartment. Double staining 
for IL2Rt~ or the transferrin receptor after 100 rain ligand 
endocytosis,  and  for  centrosomes  with  anti-centrosomal 
monoclonal  antibody,  revealed that  both  IL2Ra  and  the 
transferrin receptor were in the pericentrosomal region (not 
shown).  This peri-centrosomal compartment,  which  con- 
tains IL2Rc~ and transferrin receptors after 100 rain endocy- 
tosis, is probably the peri-centriolar recycling compartment 
(34, 59). 
The location of IL2Rct was also compared to that of the 
late endocytic compartment marker, rab 7. After 100 rain in- 
ternalization of  IL2 in the presence of 7G7B6 monoclonal an- 
tibody, the cells were fixed, permeabilized, and stained with 
anti-rab 7  antibody and then with anti-murine and anti- 
rabbit Ig labeled with FITC and TRITC, respectively. No 
colocalization of IL2Rct and rab 7 could ever be detected by 
confocal microscopy, as seen in Fig. 4, which shows a repre- 
sentative medial optical section. 
In conclusion, IL2Rt~  was at all times colocalized with 
transferrin, at early times of internalization in vesicles and 
at late times in a pericentriolar recycling compartment, and 
could  not  be  detected  together  with  the  late  endocytic 
marker, rab 7. Therefore, IL2Rot has the characteristics of 
a recycling receptor. 
The {3 Chain of lL2R Is Found in 
Late/Prelysosomal Compartments 
The same approach was used to study the location of IL2P43 
as that described above for IL2R~.  Endocytosis of IL2P~ 
was probed by internalizing IL2 together with monoclonal 
antibody 341 directed against IL2P-~. This antibody does not 
inhibit IL2 binding to high-affinity receptors (54), nor does 
it modify IL2 internalization or degradation (Fig. 2). After 
15 rain IL2 and TRITC-transferrin internalization at 37°C, 
IL2Rfl was mainly colocalized with transferrin as shown in 
Fig.  5  by confocal microscopy. Some vesicles containing 
IL2R~, but not transferrin, could already be observed. After 
100 min IL2 and transferrin internalization, transferrin was 
in the pericentriolar compartment, while IL2R~ was found 
The Journal of Cell Biology,  Volume 129, 1995  58 Figure 3. Localization after endocytosis of IL2Ra relative to transferrin. The cells were incubated at 37°C with 150 nM TRITC-transferrin, 
IL2, and anti-IL2Rt~ antibody 7G7B6. After 15 min (a-c) or 100 min (d-f), the cells were washed at 4°C to stop endocytosis, fixed, 
permeabilized, and incubated with FITC-labeled anti-murine Ig antibody.  One representative medial optical section is presented at  15 
min endocytosis (a-c) and at 100 min endocytosis (d-f). (a and d) Transferrin staining; (b and e) IL2Ra staining; (c and f) combinations 
of these two stainings.  Areas of colocalization appear yellow in the computer-generated composite image. Bar,  10 ttm. 
in vesicles which did not contain transferrin (Fig. 5). The lo- 
cation of IL2R/3 was also compared to that of rab 7  at late 
internalization  times  (100  min  at  37°C)  since  rab  7  is  a 
marker of late endocytic vesicles. IL2RB was partly colocal- 
ized with rab 7 (Fig.  5). In conclusion,  at early endocytosis 
times,  IL2R/3  was mainly  colocalized  with  transferrin,  al- 
though  a  few vesicles containing  only IL2RB were detect- 
able, and at late endocytosis times the location of IL2R/3 was 
distinct  from that of transferrin,  and in part similar to that 
of rab 7.  IL2R/3, thus,  has the characteristics  of a  receptor 
routed  towards  degradation. 
The .y Chain of IL2R Is Not Colocalized 
with Transferrin 
Endocytosis  of IL2R-r  following  IL2  binding  was  probed 
with monoclonal antibody TUGh4.  It was verified that this 
antibody, at the concentration used for immunofluorescence, 
does not inhibit IL2 binding  or modify IL2 internalization 
and degradation (Fig. 2). The cells were allowed to internal- 
ize TRITC-transferrin together with IL2 and TUGh4 for 15 
or for 100 min at 37°C.  The cells were then fixed and per- 
meabilized, and IL2R'y was revealed by FITC-labeled second 
Figure 4. Localization of 1L2Rct 
relative to rab 7. Cells were in- 
cubated  for  100  min  at  37°C 
with IL2 and 7G7B6 monoclo- 
nal  antibody,  washed  at  4°C, 
fixed,  permeabilized, and then 
stained with purified anti-rab 7 
rabbit  serum.  The  cells  were 
then  incubated  with  FITC 
anti-murine  Ig  and  TRITC 
anti-rabbit Ig. A representative 
optical  section  showing  rab  7 
(a), IL2Rct (b), and the combi- 
nation of these two images (c) is 
presented.  The cell contour is 
shown  (dotted  line).  Bar, 
10/~m. 
H~mar et al. Sorting of lL2 Receptor Chains during Endocytosis  59 Figure 5. Localization after endocytosis of IL2RB relative to transferrin and rab 7. Cells were incubated at 37°C for 15 min (a-c) or 100 
min (d-f) with 150 nM TRITC-transferrin, IL2, and anti-IL2Rl~ antibody 341. The cells were then washed at 4°C to stop endocytosis, 
fixed, permeabilized, and incubated with FITC-labeled anti-murine Ig antibody.  One representative medial optical section is presented. 
(a and d) transferrin staining; (b and e) IL21~ staining; (c and f) combination of these two stainings.  Areas of colocalization appear yellow 
in the computer-generated composite image. (g-i): Ceils were incubated for 100 min at 37 °C with IL2 and anti-IL2R/3 monoclonal antibody 
341, washed at 4°C, fixed, permeabilized, and then stained with purified anti-rab 7 rabbit serum. The cells were then incubated with FITC 
anti-murine Ig and TRITC anti-rabbit Ig. A representative medial optical section showing  rab 7 (g), IL2P-~ (h), and the combination of 
these two images (i) is presented. The cell contour is drawn (dotted line). Bar,  10 #m. 
antibodies.  Fig.  6  shows  that after  15  min internalization, 
transferrin  and  IL2R-y were  mainly  colocalized,  and  after 
100 min they were located in different compartments. There- 
fore IL2R7  is detected  in  endocytic  organelles  other  than 
early and recycling endosomes,  most likely in late/prelyso- 
somal compartments. 
Half-Life of lL2 Receptors 
The number of cell  surface receptors results  from the bal- 
ance between their rates of synthesis, internalization and re- 
cycling.  In the  presence  of cycloheximide,  synthesis  is  in- 
hibited, and therefore the number of surface receptors is the 
net result of degradation and recycling after internalization. 
We had previously reported that IL2Rot has a very long half- 
life (24),  in agreement with IL2Rot recycling after internal- 
ization.  We have now measured the half-life on the cell sur- 
face of IL2P.~ on IARC 301.5  cells in the presence of IL2 
and cycloheximide, after a  1 h preincubation with cyclohexi- 
mide.  Using the same method as described for high-affinity 
receptors  (12),  we  have  verified  that  1  h  cycloheximide 
pretreatment was sufficient to chase out the internal pool of 
/3 chain en route to the cell surface (not shown). The surface 
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IL2R'r  relative to transferrin.  Cells were in- 
cubated at 37°C with 150 nM TRITC-transfer- 
fin, IL2, and anti-IL2R-y  antibody TUGh4. Af- 
ter 15 min (a and b) or 100 min (c and d), the 
cells were washed at 4°C to stop endocytosis, 
fixed, permeabilized, and incubated with FYI~- 
labeled anti-rat Ig antibody. One representative 
medial optical section is presented at 15 min en- 
docytosis (a and b) and at 100 min endocytosis 
(c and d). (a and c) Transferrin staining and (b 
and d) IL2R3,  staining. The cell contour is drawn 
(dotted line). Bar, 10/an. 
expression of the /3  chain was  then probed  with anti-/3- 
monoclonal antibodies by flow cytofluorimetry measuring 
the mean fluorescence intensity. The half-life of  IL2Rfl in the 
presence of IL2 was about 55 min (Fig. 7 a). The same ex- 
periment was performed to measure the half-life of IL2RT, 
which was about 70 min (Fig. 7 b). Both half-lives are very 
short, among the shortest for membrane proteins, and are 
very similar to the value previously found for high-aftinity 
IL2 receptors  (11). The rapid decrease of the number of 
surface receptors  directly reflects their degradation.  This 
biochemical result confirms the data obtained by confocal 
microscopy, showing that IL2RB and IL2R3, have character- 
istics of proteins going through the degradation pathway. 
Discussion 
Communication between cells in the immune and hemato- 
poietic systems is mediated by soluble factors, the cytokines, 
which exert their biological activities through specific cell 
surface  receptors.  The  molecular  structure of a  growing 
number of cytokine receptors has been determined and led 
to the definition of a  new family of receptors.  Cytokines 
function in a  redundant manner, i.e., the same biological 
effect can be fulfilled by different cytokines. For instance 
IL2, IL4, or ILl5 may function on the same cell type as long 
as their receptors are expressed and trigger at least in part 
the same biological responses (20, 33, 39, 44). This redun- 
dancy  can  be  explained  by  the  composition  of cytokine 
receptors.  They Usually consist of ligand specific chain(s) 
and  of one  or more  chains  common to  several  cytokine 
receptors, which may be involved in signal transduction. The 
IL2 receptor is a prototype of a cytokine receptor and con- 
sists of three IL2 binding proteins, or,/3, and 3< IL2RB and 
3,  belong  to  the  cytokine family of receptors;  IL2R/3  is 
shared by the ILl5 receptor, and IL2R~ is shared at least by 
the IL4, IL7, IL9, and ILl5 receptors. 
Expression of cytokine receptors, because of their func- 
tion,  is usually tightly regulated during development and 
growth, both at the gene level and by their time of residence 
at the cell surface. Because of the participation of some of 
the chains in several receptors, and because cytokine recep- 
tors form non~ovalent multimers, it can be expected that the 
different chains may behave separately along the secretory 
and endocytic routes. This would allow for the fine regula- 
tion of expression of the different receptors. Although the 
regulation of transcription of IL2 and other cytokine recep- 
tors has been studied in detail, very little is known about 
their endocytosis and intracellular fate after cell entry. We 
have addressed this question in the case oflL2 receptors. We 
have observed that the IL2 receptor c~,/3, and 7 chains have 
different intracellular destinations despite having been inter- 
nalized together with IL2. IL2Ro~ is  found only in trans- 
ferrin-containing  compartments at all times of  IL2 endocyto- 
sis,  and  cannot be  detected in  compartments  stained by 
anti-rab 7 antibodies, as observed by confocal microscopy. 
On the other hand, IL2R~ and IL2R'y can be found in trans- 
ferrin containing vesicles at early endocytic times.  After 
prolonged endocytosis, IL2RB is also detected in rab 7 posi- 
tive organelles. However the proportion of IL2R/3 in trans- 
ferrin positive organelles is higher than that in rab 7 positive 
compartments up to  1 h endocytosis of IL2R/3 antibodies. 
This observation may be related to what was observed by 
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Figure 7. Half-lives of IL2R/3 and IL2R't.  Cell surface expression 
of IL2RB (a) or IL2R3, (b) on cells treated for different times with 
50 /zM cycloheximide and 200  pM  IL2 was assessed by cyto- 
fluorimetry. Times indicated are after a l h preincubation in cyclo- 
heximide. One representative experiment out of three is shown. 
subeellular  fractionation,  which  showed  that  internalized 
t:5I-IL2  is  mostly  found  in  transferrin-containing  endo- 
somes and not in late/prelysosomal compartments (15),  al- 
though it is known that IL2 is degraded after endocytosis. 
This suggests that IL2 and IL2RB might not accumulate for 
a long time in these rab 7 positive late/prelysosomal com- 
partments.  The  same  observation  has  been  reported  for 
epidermal growth factor receptors (26). At long times (100 
min)  of IL2  and  transferrin  endocytosis,  transferrin  and 
IL2Rct are still colocalized in a compartment with a mor- 
phology different from that observed at early internalization 
times.  We observed this pericentriolar transferrin-contain- 
ing organelle in T lymphocytes, and it appears very similar 
to that previously described in other cell types (34, 59). Al- 
most no IL2R~ or IL2R7 has ever been observed in this com- 
partment, which may thus be a specialized recycling com- 
partment. 
Taken together, these results suggest that the three chains 
of IL2R are internalized together as a quaternary complex 
with  IL2,  but are then  sorted separately within the  cell. 
However this conclusion holds only if the chains are not in- 
ternalized independently of each other. We had previously 
reported that IL2 internalized in  endocytic compartments 
could be cross-linked both to IL2Rct and IL2R~, showing 
that these two chains were internalized forming a complex 
with IL2 (13).  In this work, we demonstrate that IL2R3,  is 
also internalized. This is in agreement with the fact that, in 
cross-linking experiments, there was an additional band of 
the expected molecular weight for IL2 cross-linked to IL2R-/ 
(13). The following observations further strengthen the view 
that the chains cannot be internalized separately in the ex- 
periments reported here. (a) The IL2Ra chain is present in 
excess over the other two chains, raising the possibility that 
it could be internalized by itself. This is not the case for the 
following reasons: IL2Rot alone, without/3 and % can bind 
IL2 with a Kd =  10 nM, but then it cannot internalize IL2 
and is not internalized itself (13, 16,  17, 22, 38). Since the 
IL2 concentration used in the experiments shown here (200 
pM) is much less than the Kd, a large majority of IL2Ret on 
the  cell  surface have  no  bound  IL2.  Therefore, we  also 
checked the localization of IL2R~t  in the absence of IL2: 
IL2Rc~ was found only on the plasma membrane, and was 
never detectable in intracellular vesicles when protein syn- 
thesis was prevented by cycloheximide (not shown). IL2Ra 
is thus internalized only when part of high-affinity receptors 
formed when IL2 is present, Finally, a similar localization 
of IL2Rtx has been observed in a human natural killer cell 
line YT 12881 (not shown). This cell line bears receptors 
formed of IL2RB and IL2R3', and can be induced by ILl to 
also  express  IL2Rot  in  quantities  not  exceeding those of 
IL2P-~ (52).  (b) Concerning IL2R/3 and "y: it is highly un- 
likely that, in the presence of  IL2, some of  these chains could 
associate without IL2Rc~ because of the large excess of this 
third chain.  However, if they did, their association should 
have been detectable since IL2P,~ and IL2R-r associate in the 
presence of IL2 to form receptors of intermediate affinity, 
Kd =  1 nM (49, 55). We have never been able to detect such 
receptors on IARC 301.5, although we are capable of mea- 
suring as little as 100 receptors per cell (10). Therefore there 
is not an excess of IL2R/~ and 3' that would be internalized 
independently  of c~  in  IARC  301.5.  Likewise,  the  same 
results as reported here for IARC 301.5 were obtained with 
YT #12881  cells induced to express similar amounts of the 
three chains (not shown). 
The different intracellular localizations of the three IL2 
receptors chains therefore suggest that they have different in- 
tracellular fates, IL2Ra recycling to the plasma membrane 
while/3 and 3' are degraded, and also that their differential 
sorting occurs in endocytic organelles. The acidic pH of en- 
dosomes may play a role in this sorting, dissociating IL2 and 
the receptor's components. 
An expected consequence of sorting is that IL2Ra and 
IL2P,~ and IL2R~/should have very different half-lives. In- 
deed, IL2R43 and IL2R3, have short half-lives on the cell sur- 
face, 55 and 70 min, respectively; while we had previously 
shown that the half-life of IL2Rt~  is much longer, 48 h in 
IARC 301.5 cells (24). In this lymphocytic cell line, as well 
as in activated T lymphocytes, only about 10% of surface a 
chains are part of high-affinity receptors, while the rest of 
the c~ chains form low-affinity receptors which are not en- 
docytosed (13, 16,  17, 22,  38; and unpublished data).  We 
have previously reported that the very long half-life of IL2Rc~ 
in IARC 301.5 indicates that, following endocytosis, IL2Rc~ 
is recycled to the surface (24). In cells that do not express 
more IL2Rct than the other receptor components, one would 
expect a half-life of about 5 h for IL2Rct, assuming that most 
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tion cycle (with a recycling probability of  0.9). We have mea- 
sured the half-life of IL2Ro~, in the presence of IL2, on the 
plasnaa membrane of the natural killer human cell line YT 
12881, induced by ILl to express the same amount of  IL2Rct 
as IL2RB.  This half-life has the expected value, 5 h  (not 
shown). 
In conclusion, the different recycling or degradation be- 
havior of  chains of the same receptor that are internalized to- 
gether allows their cell surface expression to be regulated 
separately, and adds another level to the modulation due to 
regulation of gene expression. This allows the expression of 
high-affinity IL2 receptors to last for a few days, although 
the transient activation of IL2Rct gene expression following 
antigen stimulation is short (IL2Rt~ mRNA peaks at 6 h after 
antigen stimulation of T lymphocytes, while IL2RB is con- 
stantly transcribed). Furthermore, some of the chains oflL2 
receptors are also part of other cytokine receptors and their 
different behavior after endocytosis may allow for a fine bal- 
ance  to  be  achieved  between  the  expression  of  several 
cytokine receptors on the same calls. 
Sorting of proteins takes place in different compartments: 
the endoplasmic reticulum, Golgi cisternae, trans-Golgi net- 
work,  endosomes,  and plasma membrane.  The cell  ma- 
chinery involved depends on the compartment considered, 
and is in some cases well understood, while in other cases 
it remains completely unknown. All sorting processes pre- 
sumably require  sorting  signals  carried  by  some of the 
trafficking molecules. These signals are recognized by the 
cell machinery and allow the "tagged" molecules to escape 
from a default pathway and be directed to specific compart- 
ments. For molecules leaving the endosome, it is usually 
accepted that recycling occurs by default while a signal is 
required for them to be directed towards degradation com- 
partments. No such degradation signal has yet been defined. 
A sequence in P-selectin has recently provided the first ex- 
ample of  a sequence able to direct a protein towards degrada- 
tion (21). No homology has been found between this sequence 
and cytoplasmic tails either of other degraded receptors or 
of IL2RB or 7. This sequence might cause rapid lysosomal 
degradation. One of the evoked mechanisms is an aggre- 
gation of receptors routing them out of the recycling mem- 
brane (35). 
In the case of IL2 receptors,  we have shown that the tx 
chain follows the default recycling pathway, as does the trans- 
ferrin receptor. On the contrary, we assume that a degrada- 
tion signal is associated with the B and/or "t chain. We have 
previously shown that IL2RB, in the absence of IL2R-r, is 
internalized and degraded and also has a short half-life, as 
when IL2RB is part of  high-affinity  receptors (25). This indi- 
cates that IL2RB itself may carry a degradation signal in- 
dependently  of  its  association  with  IL2R-r.  Concerning 
IL2R3,, it may either carry a degradation signal itself, or re- 
main associated with IL2RB throughout the sorting process. 
Finally, the IL2 receptor is now the first multichain recep- 
tor composed of non-covalently linked subunits which has 
been shown to be sorted differentially along the endocytic 
pathway. It will be worthwhile to determine whether this is 
a  general  property  of the  expanding  family of cytokine 
receptors. 
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